REVISCON MONO 48 mg is a 2% viscoelastic solution for intra-articular use, containing 48 mg of sodium hyaluronate in 2.4 ml.
REVISCON MONO 48 mg is a 2% viscoelastic solution for intra-articular use, containing 48 mg of sodium hyaluronate in 2.4 ml.
The REVISCON range offers different volume and concentration options for assessment by healthcare professionals.
| Product | REVISCON MONO 48 mg |
|---|---|
| Component | Linear sodium hyaluronate |
| Amount | 48 mg |
| Volume | 2.4 ml |
| Concentration | 2% |
| Presentation | Pre-filled, single-use syringe |
Product selection and the administration plan are determined by the physician following clinical assessment. Intra-articular administration must be performed only by qualified healthcare professionals in an appropriate clinical setting.
This page provides product information and does not replace medical advice or the official instructions for use. Refer to the current manufacturer instructions and packaging for indications, contraindications, warnings, possible adverse effects and storage conditions.
Subscribe to our newsletter to stay updated on the latest innovations in our production and industry developments.